Coretec Group Inc (CRTG)

[flaflyersfan]

Artsy, "you don't lose until you sell" is the biggest fallacy in the penny stock market;

If a person is down $10,000-$50,000 on TDCP stock then they lost those $$$ whether they sell or not. Even worse; some "average down" and lose that money also as they cannot still sell at a loss no matter what.

The 10-K annual report for TDCP is due on March 31. I think all of the risk factors from last year's 10-K will remain the same;

We have a limited operating history, as well as a history of operating losses.


We may not be able to achieve the target specifications for the second and third generation CSpace laboratory prototypes.


We may not be able to secure the customer funding necessary to develop the CSpace Trade Show Prototype.


We may not be able to successfully license the CSpace technology to customers.


We may not be able to compete successfully.


The technologies being developed may not gain market acceptance.


If we are unable to successfully retain existing management and recruit qualified personnel having experience in our business, we may not be able to continue our operations.


Our auditors have expressed substantial doubt about our ability to continue as a going concern. If we do not continue as a going concern, investors will lose their entire investment.



We will need significant additional capital, which we may be unable to obtain.


If we fail to establish, maintain and enforce intellectual property rights with respect to our technology and/or licensed technology, our financial condition, results of operations and business could be negatively impacted.


We may face claims that we are violating the intellectual property rights of others

At this time, we do not own any intellectual property in Volumetric Liquid Crystal Display or Light Surface Display for Rendering Three-Dimensional Images, and, apart from the Sponsored Research Agreement with the University and the exclusive worldwide marketing rights thereto, we have no contracts or agreements pending to acquire the intellectual property.



There are a large number of shares underlying our convertible debentures, and warrants that may be available for future sale and the sale of these shares may depress the market price of our common stock.


The conversion price of our convertible debentures is continuously adjustable, which could require us to issue a substantially greater number of shares, which will cause dilution to our existing stockholders.


The continuously adjustable conversion price feature of our convertible debentures may encourage investors to make short sales in our common stock, which could have a depressive effect on the price of our common stock.


The issuance of shares upon conversion of the convertible debentures and exercise of outstanding warrants may cause immediate and substantial dilution to our existing stockholders.


If we are unable to issue shares of common stock upon conversion of the convertible debenture as a result of our inability to increase our authorized shares of common stock or as a result of any other reason, we are required to pay penalties to Golden State, redeem the convertible debenture at 130% and/or compensate Golden State for any buy-in that it is required to make.



The price of our common stock is volatile and fluctuations in our operating results and announcements and developments concerning our business affect our stock price, which may cause investment losses for our stockholders.


There is currently a “chill” on our Common Stock. Failure to have the “chill” removed on a timely basis could make it difficult to sell shares and may negatively affect the value of our Common Stock and our ability to raise capital.


Our common stock is subject to the "Penny Stock" rules of the SEC and the trading market in our securities is limited, which makes transactions in our stock cumbersome and may reduce the value of an investment in our stock.


Financial Industry Regulatory Authority, Inc. (“FINRA”) sales practice requirements may limit a shareholder’s ability to buy and sell our common stock.


Our stock is thinly traded, so you may be unable to sell your shares at or near the quoted bid prices if you need to sell a significant number of your shares.


Shares eligible for future sale may adversely affect the market.


We could issue additional common stock, which might dilute the book value of our common stock.


Our common stock could be further diluted as the result of the issuance of convertible securities, warrants or options.


We do not intend to pay dividends.


If we fail to maintain effective internal controls over financial reporting, the price of our common stock may be adversely affected.


We are required to comply with certain provisions of Section 404 of the Sarbanes-Oxley Act of 2002 and if we fail to comply in a timely manner, our business could be harmed and our stock price could decline.

http://www.sec.gov/Archives/edgar/data/1375195/000114420413018259/v336964_10k.htm

Good luck